Shakil S - Search Results

1

Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool.

Suhail M, AlZahrani WM, Shakil S, Tarique M, Tabrez S, Zughaibi TA, Rehan M. Suhail M, et al. Among authors: shakil s. Front Pharmacol. 2023 Oct 13;14:1236173. doi: 10.3389/fphar.2023.1236173. eCollection 2023. Front Pharmacol. 2023. PMID: 37900167 Free PMC article.

2

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment.

Jabir NR, Rehman MT, Alsolami K, Shakil S, Zughaibi TA, Alserihi RF, Khan MS, AlAjmi MF, Tabrez S. Jabir NR, et al. Among authors: shakil s. Ann Med. 2021 Dec;53(1):2332-2344. doi: 10.1080/07853890.2021.2009124. Ann Med. 2021. PMID: 34889159 Free PMC article.

3

Genotyping of interleukins-18 promoters and their correlation with coronary artery stenosis in Saudi population.

Tabrez S, Jabir NR, Zughaibi TA, Shakil S. Tabrez S, et al. Among authors: shakil s. Mol Biol Rep. 2021 Oct;48(10):6695-6702. doi: 10.1007/s11033-021-06658-6. Epub 2021 Aug 24. Mol Biol Rep. 2021. PMID: 34431037

4

Galectins-A Potential Target for Cardiovascular Therapy.

Ashraf GM, Perveen A, Zaidi SK, Ahmad A, Shakil S, Firoz CK, Jabir NR, Hassan I, Khan TA, Yarla NS, Tabrez S. Ashraf GM, et al. Among authors: shakil s. Curr Vasc Pharmacol. 2017;15(4):296-312. doi: 10.2174/1570161115666170201113046. Curr Vasc Pharmacol. 2017. PMID: 28155611 Review.

5

Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease.

Jabir NR, Firoz CK, Ashraf GM, Zaidi SK, Shakil S, Kamal MA, Tabrez S. Jabir NR, et al. Among authors: shakil s. Curr Vasc Pharmacol. 2017;15(4):365-373. doi: 10.2174/1570161115666170105125034. Curr Vasc Pharmacol. 2017. PMID: 28056755 Review.

6

In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.

Jabir NR, Shakil S, Tabrez S, Khan MS, Rehman MT, Ahmed BA. Jabir NR, et al. Among authors: shakil s. J Biomol Struct Dyn. 2021 Sep;39(14):5083-5092. doi: 10.1080/07391102.2020.1784796. Epub 2020 Jun 26. J Biomol Struct Dyn. 2021. PMID: 32588759

7

Nanotechnology-based approaches in anticancer research.

Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Jabir NR, et al. Among authors: shakil s. Int J Nanomedicine. 2012;7:4391-408. doi: 10.2147/IJN.S33838. Epub 2012 Aug 9. Int J Nanomedicine. 2012. PMID: 22927757 Free PMC article. Review.

8

Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases.

Jabir NR, Siddiqui AN, Firoz CK, Ashraf GM, Zaidi SK, Khan MS, Shakil S, Alama MN, Kamal MA, Tabrez S. Jabir NR, et al. Among authors: shakil s. Curr Pharm Des. 2016;22(5):566-71. doi: 10.2174/1381612822666151125000746. Curr Pharm Des. 2016. PMID: 26601967 Review.

9

Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy.

Shakil S, Baig MH, Tabrez S, Rizvi SMD, Zaidi SK, Ashraf GM, Ansari SA, Khan AAP, Al-Qahtani MH, Abuzenadah AM, Chaudhary AG. Shakil S, et al. Semin Cancer Biol. 2019 Jun;56:47-55. doi: 10.1016/j.semcancer.2017.11.004. Epub 2017 Nov 6. Semin Cancer Biol. 2019. PMID: 29122685 Review.

10

Association of Plasma Fibrinogen Level with Insulin Resistance in Angiographically Confirmed Coronary Artery Disease Patients.

Tabrez S, Jabir NR, Shakil S, Alama MN. Tabrez S, et al. Among authors: shakil s. Crit Rev Eukaryot Gene Expr. 2019;29(3):277-285. doi: 10.1615/CritRevEukaryotGeneExpr.2019030063. Crit Rev Eukaryot Gene Expr. 2019. PMID: 31679237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters